BRIC Countries (Brazil, Russia, India, China) Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
BRIC Countries (Brazil, Russia, India, China) Generics Market Summary, Competitive Analysis and Forecast, 2017-2026Summary
The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the generics industry and had a total market value of $114,747.5 million in 2021. Russia was the fastest growing country with a CAGR of 10.7% over the 2017-21 period.
- Within the generics industry, China is the leading country among the BRIC nations with market revenues of $85,327.0 million in 2021. This was followed by India, Russia and Brazil with a value of $17,283.5, $9,801.3, and $2,335.6 million, respectively.
- China is expected to lead the generics industry in the BRIC nations with a value of $102,263.8 million in 2026, followed by India, Russia, Brazil with expected values of $26,692.2, $14,529.5 and $3,309.4 million, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC generics market
- Leading company profiles reveal details of key generics market players’ BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC generics market with five year forecasts by both value and volume
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
Reasons to Buy
- What was the size of the BRIC generics market by value in 2021?
- What will be the size of the BRIC generics market in 2026?
- What factors are affecting the strength of competition in the BRIC generics market?
- How has the market performed over the last five years?
- How large is the BRIC generics market in relation to its regional counterparts?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.